DK234789A - Antistoffer mod latente human papillomavirusproteiner, diagnostiske systemer og diagnostiske metoder - Google Patents

Antistoffer mod latente human papillomavirusproteiner, diagnostiske systemer og diagnostiske metoder Download PDF

Info

Publication number
DK234789A
DK234789A DK234789A DK234789A DK234789A DK 234789 A DK234789 A DK 234789A DK 234789 A DK234789 A DK 234789A DK 234789 A DK234789 A DK 234789A DK 234789 A DK234789 A DK 234789A
Authority
DK
Denmark
Prior art keywords
diagnostic
antibodies against
human papillomavirus
papillomavirus proteins
systems
Prior art date
Application number
DK234789A
Other languages
English (en)
Other versions
DK234789D0 (da
DK173264B1 (da
Inventor
Joakim Dillner
Richard A Lerner
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK234789D0 publication Critical patent/DK234789D0/da
Publication of DK234789A publication Critical patent/DK234789A/da
Application granted granted Critical
Publication of DK173264B1 publication Critical patent/DK173264B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK198902347A 1988-05-16 1989-05-12 Polypeptider, som reagerer med antistoffer mod latente human papillomavirusproteiner, antistoffer, som reagerer med polype DK173264B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19440788A 1988-05-16 1988-05-16
US19440788 1988-05-16
US32361489 1989-03-13
US07/323,614 US5180806A (en) 1988-05-16 1989-03-13 Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods

Publications (3)

Publication Number Publication Date
DK234789D0 DK234789D0 (da) 1989-05-12
DK234789A true DK234789A (da) 1989-11-17
DK173264B1 DK173264B1 (da) 2000-05-29

Family

ID=26889974

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902347A DK173264B1 (da) 1988-05-16 1989-05-12 Polypeptider, som reagerer med antistoffer mod latente human papillomavirusproteiner, antistoffer, som reagerer med polype

Country Status (10)

Country Link
US (3) US5180806A (da)
EP (1) EP0344940B1 (da)
JP (1) JP2918904B2 (da)
AT (1) ATE130855T1 (da)
CA (1) CA1341287C (da)
DE (1) DE68924928T2 (da)
DK (1) DK173264B1 (da)
ES (1) ES2082775T4 (da)
GR (1) GR3018773T3 (da)
PT (1) PT90574B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932412A (en) * 1990-05-11 1999-08-03 Euro-Diagnostica Ab Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
SE9001705D0 (sv) * 1990-05-11 1990-05-11 Medscand Ab Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
DK0510912T3 (da) * 1991-04-24 1998-02-09 Morinaga Milk Industry Co Ltd Antimikrobielt peptid og antimikrobielt middel
PT523391E (pt) * 1991-07-13 2003-08-29 Dade Behring Marburg Gmbh Utilizacao dos peptidos derivados dos genes hpv-16 e6 e e7 para fins de diagnostico
DE4123760C2 (de) * 1991-07-18 2000-01-20 Dade Behring Marburg Gmbh Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
DE19819476C1 (de) * 1998-04-30 2000-01-05 Deutsches Krebsforsch Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins
GB2353581B (en) 1999-08-27 2003-06-11 Uponor Ltd Swage lining
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
JP2001172200A (ja) * 1999-12-17 2001-06-26 Meneki Seibutsu Kenkyusho:Kk ヒトナプシンaに対する抗体およびこれを用いる医薬
US6743593B2 (en) 2000-04-05 2004-06-01 Impact Diagnostics, Inc. Immunological methodology for discerning human papillomavirus
US7202034B2 (en) 2000-12-08 2007-04-10 Academisch Ziekenhuis Leiden Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
EP1288292A1 (en) * 2001-08-31 2003-03-05 Leids Universitair Medisch Centrum Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses.
AU2002232722A1 (en) * 2000-12-21 2002-07-01 Biosignature Diagnostics, Inc. Absorbance multiplex technology
US6933123B2 (en) 2001-04-05 2005-08-23 Yao Xiong Hu Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
GB2379220A (en) * 2001-08-13 2003-03-05 Univ York Antibodies to HPV E2 protein
WO2005025497A2 (en) * 2003-09-05 2005-03-24 Genencor International, Inc. Hpv cd8+ t-cell epitopes
JP5030594B2 (ja) * 2003-12-23 2012-09-19 アルボー ビータ コーポレーション Hpvの発癌性株に対する抗体およびそれらの使用方法
WO2005089164A2 (en) * 2003-12-31 2005-09-29 Pharmexa Inc. Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US8051950B2 (en) * 2006-08-03 2011-11-08 Glacier Bay, Inc. System for reducing acoustic energy
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8916342B2 (en) 2006-11-13 2014-12-23 Oncohealth Corp. Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
US20100003704A1 (en) 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
ES2482192T3 (es) * 2007-05-31 2014-08-01 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Vacunación intradérmica del péptido de HPV
CN107617110A (zh) * 2009-08-26 2018-01-23 西莱克塔生物科技公司 诱导t细胞辅助的组合物
EP2521914A4 (en) 2010-01-08 2013-07-10 Oncohealth Corp CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER
US20110171248A1 (en) * 2010-01-08 2011-07-14 Selecta Biosciences, Inc. Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
CN103940993A (zh) * 2013-01-23 2014-07-23 艾托金生物医药(苏州)有限公司 用于检测抗人乳头瘤病毒抗体的抗原及试剂盒和应用
JP7401312B2 (ja) * 2017-06-28 2023-12-19 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 抗ヒトパピローマウイルス(hpv)抗原結合性タンパク質およびその使用方法
CN111868074A (zh) * 2018-01-24 2020-10-30 昆士兰医学研究所理事会 Hpv免疫疗法
KR20210029280A (ko) 2018-08-02 2021-03-15 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 질환을 제거하기 위한 체크포인트-억제 항체와 상승작용하는 tlr1/2 작용제 디프로보심의 애쥬번트 효과
US11975106B2 (en) 2020-03-26 2024-05-07 Provectus Pharmatech, Inc. Uses of halogenated xanthenes in oncology and virology
US11938182B2 (en) 2020-03-26 2024-03-26 Provectus Pharmatech, Inc. Halogenated xanthenes as vaccine adjuvants
CN112920267B (zh) * 2021-03-09 2021-08-13 北京康乐卫士生物技术股份有限公司 一种抗人乳头瘤病毒31型的单克隆中和抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6089755A (ja) * 1983-07-01 1985-05-20 フイリツプ・ジヨン・ベア−ド 診断用試薬及びその製造法並びにそれを用いる診断法
LU85462A1 (fr) * 1984-07-11 1986-02-12 Univ Louvain Nouvelles compositions polymeres,procedes pour leur production et leurs applications
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus

Also Published As

Publication number Publication date
DE68924928D1 (de) 1996-01-11
ES2082775T4 (es) 1996-08-01
GR3018773T3 (en) 1996-04-30
JPH0296593A (ja) 1990-04-09
PT90574A (pt) 1989-11-30
PT90574B (pt) 1994-09-30
DK234789D0 (da) 1989-05-12
EP0344940A2 (en) 1989-12-06
ATE130855T1 (de) 1995-12-15
CA1341287C (en) 2001-08-28
JP2918904B2 (ja) 1999-07-12
US5401627A (en) 1995-03-28
DE68924928T2 (de) 1996-10-17
US5486453A (en) 1996-01-23
EP0344940B1 (en) 1995-11-29
US5180806A (en) 1993-01-19
EP0344940A3 (en) 1991-11-13
ES2082775T3 (es) 1996-04-01
DK173264B1 (da) 2000-05-29

Similar Documents

Publication Publication Date Title
DK234789A (da) Antistoffer mod latente human papillomavirusproteiner, diagnostiske systemer og diagnostiske metoder
IT1083606B (it) Contenitore particolarmente provetta per analisi o procedure immuno chomiche ed enzimatiche e procedimento per la sua fabbricazione
DE69228701D1 (de) Fragmente von Prion Proteinen.
DK101890A (da) Monoklonale antistoffer mod human interleukin-4 og hybridomaer, der producerer saadanne
DE59010787D1 (de) Erythropoietin (EPO)-Peptide und dagegen gerichtete Antikörper
DK412284A (da) Vacciner baseret paa membran-bundne proteiner og fremgangsmaade til fremstilling deraf
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
NO901349L (no) Fremgangsmaate for maaling eller testing.
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
DE3887053D1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
NO892269D0 (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
DE3485219D1 (de) Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper.
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
ES2103017T3 (es) Sueros estandares y de control para empleo en ensayos para anticuerpos.
DE3650635T2 (de) Monoklonale Antikörper
DK116487A (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
ATE114818T1 (de) Immuntest zum nachweis von alpha-haloacetamiden.
DE3886032T2 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
DK604689D0 (da) Peptider, og analysesaet med indhold af saadanne forbindelser
DK698288A (da) Stlv-iii-relaterede polypeptider, diagnostiske systemer og bestemmelsesmetoder
ATE97915T1 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
DE8817263U1 (de) Enzymimmunoassay zum Nachweis von Anti-Tetanus-Antikörpern
DK305084A (da) Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen
NO900048D0 (no) Paavisningsmetoder med individ-spesifikke antistoff.
ATE50452T1 (de) Mittel zum antigen/antikoerper-nachweis.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired